Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

Monday’s trading has closed, but CELG is being traded in the after-hours session. After-Hours quote »
131.47
Delayed Data
As of 3:59pm ET
 +0.22 / +0.17%
Today’s Change
83.16
Today|||52-Week Range
140.72
+17.53%
Year-to-Date
Celgene Buying Opportunity on the Way?
11:03am / TheStreet.com
Celgene Delivers as Expected in Q2, but Raises New Questions
Jul 24 / MotleyFool.com
'Fast Money' Recap: Goodbye, July; Will August Be More of the Same?
Aug 01 / TheStreet.com
Celgene Q2 Earnings & Revenues In Line, Keeps View - Analyst Blog
Jul 23 / Zacks.com
AstraZeneca Beats on Q2 Earnings, Revises Revenue View - Analyst Blog
Jul 31 / Zacks.com
Celgene Rolling Along (but You Already Knew That)
Jul 23 / MotleyFool.com
Celgene is pushed into paying a high price for Receptos
Jul 30 / FT.com
Celgene (CELG) Reports In Line Q2 Earnings and Revenues - Tale of the Tape
Jul 23 / Zacks.com
Price Isn't a Problem for Gilead Sciences
Jul 30 / TheStreet.com
5 Reasons Celgene Corporation Is a Buy
Jul 22 / MotleyFool.com
Price Isn't a Problem for Gilead Sciences
Jul 30 / TheStreet.com
Celgene Buys Receptos. Is Arena Pharmaceuticals Next?
Jul 21 / MotleyFool.com
3 Stocks Pushing The Drugs Industry Lower
Jul 29 / TheStreet.com
What's in Store for Celgene (CELG) This Earnings Season? - Analyst Blog
Jul 21 / Zacks.com
Stock Market News for July 29, 2015 - Market News
Jul 29 / Zacks.com
Record fundraisings wake UK life sciences from slumber
Jul 21 / FT.com
Amp Up Your Portfolio With These Biotech Stocks
Jul 29 / MotleyFool.com
3 Questions Investors Should Ask When Celgene Reports Its Second-Quarter Results
Jul 21 / MotleyFool.com
3 Big Biotech Buybacks That Investors Should Love
Jul 28 / MotleyFool.com
Cautionary tale as Receptos benefits from buying frenzy
Jul 17 / FT.com
Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog
Jul 27 / Zacks.com
Acquisitive Celgene shuns usual biotech growth model
Jul 16 / FT.com
Stock Market News for July 27, 2015 - Market News
Jul 27 / Zacks.com
European biotechs rush to list on Nasdaq
Jul 15 / FT.com
Biotech high flyers face gravity test
Jul 27 / FT.com
Celgene: tomorrow's growth today
Jul 15 / FT.com
1 ETF Thatbs Crushing Even Warren Buffett
Jul 25 / MotleyFool.com
Biotech boon as Celgene agrees $7.2bn Receptos deal
Jul 14 / FT.com